FIELD: biotechnology.
SUBSTANCE: method is proposed for renatured protein G isolation from the marked polyacrylamide gel. The proposed method includes the steps of marking of the protein G position in a polyacrylamide gel, separation of fragment of the marked gel containing protein G, sequential treatment of the gel fragment with a denaturing buffer solution containing 20 mM of Tris (pH 8.0), 100 mM of NaCl, 1% Triton X-100, 6 M urea, 2 M thiourea for 1 hour and a renaturing buffer solution containing 20 mM of Tris (pH 8.0), 100 mM of NaCl, 2 mM of sulfobetaine, 1 mM of EDTA, for 3 hours at 20°C with a three-fold change in the buffer and final electro-elution of the renatured protein G from the ground gel in a buffer solution containing 10 mM potassium phosphate buffer (pH 7.5), for 2 hours and at a current strength of 200 mA.
EFFECT: method can be used to isolate protein G, which has preserved immunobiological properties.
7 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SENSIBILIZATION OF PLATE FOR ENZYME IMMUNOASSAY BY INSOLUBLE PROTEIN ANTIGENS | 2019 |
|
RU2732013C1 |
TEST SYSTEM FOR DIAGNOSTICS OF AGENTS OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2019 |
|
RU2733379C1 |
DIAGNOSTIC TECHNIQUE FOR AGENTS OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2019 |
|
RU2726797C1 |
METHOD FOR OBTAINING ACTIVE STARTING OF VACCINE AGAINST ROTAVIRUS INFECTION OF PROTEIN FLiCVP6VP8 | 2017 |
|
RU2649132C1 |
METHOD FOR PREPARING, ISOLATING, PURIFYING AND STABILIZING HUMAN RECOMBINANT GRANULOCYTIC COLONY-STIMULATING FACTOR USEFUL FOR MEDICINAL USING AND IMMUNOBIOLOGICAL AGENT BASED ON THEREOF | 2004 |
|
RU2278870C2 |
RECOMBINANT PLASMIDS pET32a-TNF-Thy, PROVIDING SYNTHESIS OF HYBRID PROTEIN α-TUMOR NECROSIS FACTOR - THYMOSIN ALPHA 1, BACTERIAL STRAIN ESCHERICHIA COLI BL21 (DE3)/pET32a-TNF-Thy - PRODUCER OF HYBRID PROTEIN TNF-Thy, METHOD OF OBTAINING TNF HYBRID PROTEIN-Thy AND MEDICINAL PRODUCT | 2022 |
|
RU2809355C1 |
METHOD OF PREPARING HUMAN RECOMBINANT GRANULOCYTIC COLONY-STIMULATING FACTOR | 2001 |
|
RU2201962C2 |
RECOMBINANT PLASMID DNA pHINS11 CODING HYBRID PROTEIN-HUMAN INSULIN PRECURSOR, Escherichia coli CELL, TRANSFORMED WITH RECOMBINANT PLASMID DNA pHINS11, Escherichia coli BACTERIA STRAIN JM109/pHINS11 - PRODUCER OF HYBRID PROTEIN-HUMAN INSULIN PRECURSOR, AND METHOD OF OBTAINING HUMAN INSULIN | 2006 |
|
RU2354702C2 |
RECOMBINANT pET32A-TNF-Thy PLASMIDE PROVIDING THE SYNTHESIS OF THE FUSION PROTEIN Α-TUMOR NECROSIS FACTOR - THYMOSIN ALPHA 1, BACTERIAL STRAIN ESCHERICHIA COLI BL21(DE3)/pET32a-THF-Thy - PRODUCER OF THE HYBRID PROTEIN TNF-THY AND TNF-THY Thy | 2022 |
|
RU2787531C1 |
METHOD FOR INDUSTRIAL PREPARING HUMAN RECOMBINANT INSULIN | 2003 |
|
RU2232813C1 |
Authors
Dates
2018-03-01—Published
2016-03-30—Filed